|
|
cellular response to laminar fluid shear stress
|
GO:0071499 |
5 |
0.997
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.983
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
3 |
0.974
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
2 |
0.961
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
7 |
0.940
|
|
|
|
regulation of oxidative stress induced cell death
|
GO:1903201 |
24 |
0.922
|
|
|
|
proteasomal ubiquitin independent protein catabolic process
|
GO:0010499 |
3 |
0.890
|
|
|
|
negative regulation of oxidative stress induced cell death
|
GO:1903202 |
17 |
0.888
|
|
|
|
regulation of transcription involved in g2 m transition of mitotic cell cycle
|
GO:0000117 |
1 |
0.883
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
29 |
0.882
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
16 |
0.874
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
1 |
0.864
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
21 |
0.860
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.837
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.834
|
|
|
|
cell death in response to hydrogen peroxide
|
GO:0036474 |
10 |
0.828
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.814
|
|
|
|
regulation of cell maturation
|
GO:1903429 |
3 |
0.776
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.773
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.713
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.711
|
|
|
|
cellular response to hydrogen peroxide
|
GO:0070301 |
37 |
0.708
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.698
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
9 |
0.684
|
|
|
|
negative regulation of hydrogen peroxide induced cell death
|
GO:1903206 |
9 |
0.671
|
|
|
|
regulation of oocyte development
|
GO:0060281 |
1 |
0.658
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.656
|
|
|
|
negative regulation of cellular response to oxidative stress
|
GO:1900408 |
18 |
0.646
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.645
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
26 |
0.632
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
8 |
0.631
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.624
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.607
|
|
|
|
regulation of response to reactive oxygen species
|
GO:1901031 |
12 |
0.604
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.595
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
26 |
0.586
|
|
|
|
negative regulation of response to oxidative stress
|
GO:1902883 |
18 |
0.573
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.553
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.549
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.546
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.545
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.540
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
41 |
0.537
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.525
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.520
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.511
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.493
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.490
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
24 |
0.490
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.477
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.471
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.456
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.453
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.442
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.435
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.435
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.423
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.409
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
7 |
0.402
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.399
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
26 |
0.396
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
49 |
0.392
|
|
|
|
regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902175 |
16 |
0.382
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.374
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.365
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.364
|
|
|
|
regulation of hydrogen peroxide induced cell death
|
GO:1903205 |
10 |
0.352
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
40 |
0.327
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
40 |
0.317
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.302
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.301
|
Human |
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.294
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.284
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.279
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.276
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.271
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.269
|
|
|
|
hemostasis
|
GO:0007599 |
76 |
0.265
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.263
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.256
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.252
|
Fly |
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.250
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.248
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
6 |
0.246
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.238
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
17 |
0.238
|
|
|
|
negative regulation of response to reactive oxygen species
|
GO:1901032 |
10 |
0.236
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.232
|
|
|
|
positive regulation of blood coagulation
|
GO:0030194 |
11 |
0.226
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.224
|
Human Mouse |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.219
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.214
|
|
|
|
neurofilament bundle assembly
|
GO:0033693 |
2 |
0.211
|
|
|
|
cellular response to topologically incorrect protein
|
GO:0035967 |
19 |
0.210
|
|
|
|
dorsal ventral axis specification
|
GO:0009950 |
7 |
0.210
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.210
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.205
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.198
|
|
|
|
cellular response to reactive oxygen species
|
GO:0034614 |
50 |
0.185
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.177
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
23 |
0.172
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.172
|
|
|
|
endoplasmic reticulum unfolded protein response
|
GO:0030968 |
16 |
0.170
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.163
|
|
|
|
rna localization
|
GO:0006403 |
41 |
0.161
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.160
|
Human |
|
|
protein k33 linked ubiquitination
|
GO:1990390 |
1 |
0.159
|
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
10 |
0.156
|
|
|
|
response to unfolded protein
|
GO:0006986 |
24 |
0.149
|
|
|
|
response to fluid shear stress
|
GO:0034405 |
14 |
0.149
|
|
|
|
response to topologically incorrect protein
|
GO:0035966 |
29 |
0.147
|
|
|
|
cellular response to unfolded protein
|
GO:0034620 |
16 |
0.147
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
18 |
0.144
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.144
|
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
15 |
0.143
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.140
|
|
|
|
regulation of wound healing
|
GO:0061041 |
56 |
0.140
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.132
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
42 |
0.129
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.125
|
|
|
|
developmental maturation
|
GO:0021700 |
28 |
0.123
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.121
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
20 |
0.118
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.113
|
|
|
|
embryonic axis specification
|
GO:0000578 |
5 |
0.113
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.109
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
61 |
0.105
|
|
|
|
positive regulation of hemostasis
|
GO:1900048 |
11 |
0.101
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.099
|
Human |
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.098
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.097
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.096
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.095
|
Mouse |
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.093
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.089
|
|
|
|
negative regulation of erythrocyte differentiation
|
GO:0045647 |
3 |
0.087
|
Human |
|
|
response to laminar fluid shear stress
|
GO:0034616 |
8 |
0.085
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.084
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
6 |
0.083
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.082
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.079
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to oxidative stress
|
GO:0043619 |
5 |
0.078
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.076
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.076
|
|
|
|
head development
|
GO:0060322 |
108 |
0.075
|
Fly |
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.075
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
42 |
0.072
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
20 |
0.070
|
|
|
|
chromosome passenger complex localization to spindle midzone
|
GO:0035853 |
1 |
0.068
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.067
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.066
|
|
|
|
axis specification
|
GO:0009798 |
12 |
0.066
|
|
|
|
vesicle targeting rough er to cis golgi
|
GO:0048207 |
2 |
0.060
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.059
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.058
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
63 |
0.058
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.056
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.055
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.055
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
44 |
0.053
|
|
|
|
embryonic pattern specification
|
GO:0009880 |
5 |
0.050
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
31 |
0.050
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.047
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.047
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.047
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.047
|
Human |
|
|
neuron projection morphogenesis
|
GO:0048812 |
50 |
0.046
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.045
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.044
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.043
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.042
|
Human |
|
|
cell projection organization
|
GO:0030030 |
252 |
0.041
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.040
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.040
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.039
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.039
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.038
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.038
|
|
|
|
system process
|
GO:0003008 |
349 |
0.038
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.038
|
|
|
|
neurofilament cytoskeleton organization
|
GO:0060052 |
2 |
0.038
|
|
|
|
renal sodium ion absorption
|
GO:0070294 |
2 |
0.037
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.035
|
Human |
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.035
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.035
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.035
|
|
|
|
aging
|
GO:0007568 |
66 |
0.033
|
|
|
|
protein k48 linked ubiquitination
|
GO:0070936 |
38 |
0.033
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.033
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.032
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.032
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.031
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.031
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.031
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
15 |
0.031
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.030
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.030
|
Mouse |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.030
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
11 |
0.030
|
|
|
|
negative regulation of synaptic transmission
|
GO:0050805 |
2 |
0.030
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.030
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.030
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.029
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.029
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.029
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
80 |
0.028
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.028
|
Human |
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.028
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.028
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.027
|
Human |
|
|
cytokine production
|
GO:0001816 |
247 |
0.027
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
2 |
0.027
|
|
|
|
sodium ion transport
|
GO:0006814 |
61 |
0.027
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to oxidative stress
|
GO:0036091 |
3 |
0.026
|
|
|
|
blood vessel maturation
|
GO:0001955 |
1 |
0.026
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.026
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
20 |
0.026
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.025
|
|
|
|
regulation of neurotransmitter secretion
|
GO:0046928 |
3 |
0.025
|
|
|
|
negative regulation of neurological system process
|
GO:0031645 |
2 |
0.025
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.025
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.025
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.025
|
|
|
|
dendrite morphogenesis
|
GO:0048813 |
14 |
0.025
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.025
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.025
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.025
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.024
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.024
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.024
|
Human |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.024
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.024
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
17 |
0.023
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.023
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.023
|
Human |
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.023
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.023
|
|
|
|
growth
|
GO:0040007 |
202 |
0.023
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.023
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.023
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.022
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.022
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.022
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.022
|
Human |
|
|
chromatin organization
|
GO:0006325 |
351 |
0.022
|
|
|
|
distal tubule morphogenesis
|
GO:0072156 |
3 |
0.022
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.022
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.022
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.022
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.022
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.022
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
54 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.021
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.021
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.021
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
9 |
0.021
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.021
|
Mouse |
|
|
hindbrain development
|
GO:0030902 |
3 |
0.021
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.021
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.020
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.020
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.020
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.020
|
Human |
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.020
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.020
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.019
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.019
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.019
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.019
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.019
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.019
|
Mouse |
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.019
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.019
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.019
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.019
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.018
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.018
|
|
|
|
dendrite development
|
GO:0016358 |
24 |
0.018
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.018
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.018
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.018
|
|
|
|
positive regulation of transcription during mitosis
|
GO:0045897 |
2 |
0.018
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.018
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.018
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.017
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.017
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.017
|
|
|
|
demethylation
|
GO:0070988 |
37 |
0.017
|
|
|
|
regulation of synaptic vesicle exocytosis
|
GO:2000300 |
2 |
0.017
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.017
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
52 |
0.017
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.017
|
|
|
|
protein monoubiquitination
|
GO:0006513 |
39 |
0.017
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.017
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.017
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.017
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.017
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.017
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.017
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.017
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
4 |
0.016
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.016
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.016
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.016
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.016
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.016
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.016
|
|
|
|
multicellular organism reproduction
|
GO:0032504 |
42 |
0.016
|
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.016
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.016
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.016
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.016
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.016
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.016
|
|
|
|
response to salt stress
|
GO:0009651 |
3 |
0.016
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.016
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.016
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.016
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.016
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.016
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.016
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.016
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.015
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.015
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.015
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.015
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.015
|
|
|
|
determination of dorsal ventral asymmetry
|
GO:0048262 |
4 |
0.015
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.015
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.015
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.015
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.015
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.015
|
|
|
|
regulation of transcription during mitosis
|
GO:0045896 |
2 |
0.015
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.015
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.015
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.015
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.015
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.015
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.015
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.015
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.015
|
Fly |
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.015
|
|
|
|
vesicle organization
|
GO:0016050 |
62 |
0.015
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.015
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.015
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.015
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.015
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.015
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.014
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
4 |
0.014
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.014
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
19 |
0.014
|
Mouse |
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.014
|
|
|
|
response to superoxide
|
GO:0000303 |
6 |
0.014
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.014
|
|
|
|
response to oxygen radical
|
GO:0000305 |
6 |
0.014
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.014
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.014
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
49 |
0.014
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.014
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.014
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.014
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.014
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
59 |
0.014
|
Human |
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.014
|
|
|
|
copii vesicle coating
|
GO:0048208 |
2 |
0.014
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.014
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.014
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.014
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.014
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.014
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.014
|
|
|
|
axon cargo transport
|
GO:0008088 |
2 |
0.014
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.013
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.013
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.013
|
|
|
|
synaptic vesicle exocytosis
|
GO:0016079 |
3 |
0.013
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.013
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.013
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.013
|
Mouse |
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.013
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.013
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.013
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.013
|
|
|
|
cell maturation
|
GO:0048469 |
11 |
0.013
|
|
|
|
regulation of superoxide metabolic process
|
GO:0090322 |
6 |
0.013
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.013
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.013
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.013
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.013
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.013
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.013
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.013
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.013
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.013
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
3 |
0.013
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.013
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.013
|
|
|
|
protein localization to cytoskeleton
|
GO:0044380 |
11 |
0.012
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.012
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.012
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.012
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.012
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.012
|
|
|
|
regulation of dna repair
|
GO:0006282 |
47 |
0.012
|
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.012
|
|
|
|
regulation of glial cell proliferation
|
GO:0060251 |
4 |
0.012
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.012
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.012
|
|
|
|
dicarboxylic acid metabolic process
|
GO:0043648 |
29 |
0.012
|
|
|
|
memory
|
GO:0007613 |
3 |
0.012
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.012
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.012
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.012
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.012
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.012
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.012
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.012
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.012
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.012
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.012
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.012
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.012
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
13 |
0.012
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.012
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.011
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.011
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.011
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.011
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.011
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.011
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.011
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.011
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.011
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.011
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.011
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.011
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.011
|
Human |
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.011
|
|
|
|
regulation of axon extension involved in axon guidance
|
GO:0048841 |
2 |
0.011
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.011
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.011
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.011
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.011
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
4 |
0.011
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.011
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.011
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.011
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.011
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.011
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.011
|
|
|
|
ncrna metabolic process
|
GO:0034660 |
108 |
0.011
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.011
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.011
|
|
|
|
patterning of blood vessels
|
GO:0001569 |
2 |
0.011
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.011
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.011
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.011
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.011
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.011
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.011
|
|
|
|
distal tubule development
|
GO:0072017 |
4 |
0.011
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.010
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.010
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.010
|
|
|
|
membrane budding
|
GO:0006900 |
28 |
0.010
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.010
|
|
|
|
regulation of synaptic vesicle transport
|
GO:1902803 |
3 |
0.010
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
71 |
0.010
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.010
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.010
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
1 |
0.010
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.010
|
|
|
|
organic acid transport
|
GO:0015849 |
65 |
0.010
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.010
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.010
|
|
|
|
nephron epithelium development
|
GO:0072009 |
23 |
0.010
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
3 |
0.010
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.010
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.010
|
|
